These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 9348575

  • 1. Preliminary results. UFT/methotrexate/leucovorin for breast Ca patients in progression after HDCT/PBPC support.
    Martin M, Casado A, López-Martin JA, Rodriguez-Lescure A, Nieto Y, Ayala F, Diaz-Rubio E.
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):83-5. PubMed ID: 9348575
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate, uracil and tegafur, and leucovorin chemotherapy for patients with breast cancer in progression after high-dose chemotherapy with peripheral blood progenitor cell transplant: a phase II study.
    Martín M, Casado A, Macias JA, Garcia-Carbonero I, Garcia-Saenz JA, Oruezabal M, Manrique I, Diaz-Rubio E.
    Am J Clin Oncol; 2000 Dec; 23(6):617-21. PubMed ID: 11202810
    [Abstract] [Full Text] [Related]

  • 3. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A, Albanell J, Solé-Calvo LA, Gallardo E, Bellmunt J, Vera R, Vidal R, Carulla J, Baselga J.
    Cancer; 1998 Mar 01; 82(5):878-85. PubMed ID: 9486577
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.
    Hortobagyi GN, Young RR, Karwal M, Ibrahim NK, Hermann R, Murray JL, Watkins SP, Gore I.
    Cancer; 2010 May 15; 116(10):2301-6. PubMed ID: 20225231
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J, González Barón M, García-Girón C, Espinosa E, García-Alfonso P, Belón J, Blanco E, Garrido P, Ordónez A, Gómez-Navarro J, Zamora P.
    Cancer; 1996 Jul 15; 78(2):211-6. PubMed ID: 8673994
    [Abstract] [Full Text] [Related]

  • 9. [Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
    Mizushima T, Mizuno H, Ito T, Hoki M, Souma Y, Iwamoto T, Ozawa H, Kanou T, Nakamori Y, Iwase K.
    Gan To Kagaku Ryoho; 2006 Jul 15; 33(7):941-4. PubMed ID: 16835484
    [Abstract] [Full Text] [Related]

  • 10. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT, Yoon SY, Shin SW, Kim BS, Mok YJ, Kim CS, Hyun JH, Kim JS, Kim YH.
    Cancer; 2001 Jun 15; 91(12):2288-93. PubMed ID: 11413517
    [Abstract] [Full Text] [Related]

  • 11. Phase I trial of uracil-ftorafur, leucovorin, and etoposide: an active all-oral regimen for metastatic breast cancer.
    Hartman AR, Grekowicz A, Lum BL, Carlson RW, Schurman C, Sikic BI, Shapiro R, Stockdale FE.
    Breast Cancer Res Treat; 2003 Nov 15; 82(1):61-9. PubMed ID: 14672404
    [Abstract] [Full Text] [Related]

  • 12. A preliminary report of a phase II trial. UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Spanish Group for the Treatment of Gastrointestinal Tumors (TTd Group).
    Abad A, Navarro M, Sastre J, Marcuello E, Aranda E, Gallén M, Fernandez-Martos C, Martín C, Diaz-Rubio E.
    Oncology (Williston Park); 1997 Sep 15; 11(9 Suppl 10):53-7. PubMed ID: 9348570
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 14. UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancer.
    Gregory RK, Johnston SR, Smith IE, Miles D.
    Oncology (Williston Park); 2000 Oct 15; 14(10 Suppl 9):47-9. PubMed ID: 11098493
    [Abstract] [Full Text] [Related]

  • 15. Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study.
    Surmont V, Aerts JG, Pouw E, Tan KY, Vernhout R, Gras J, Salomé J, Pronk T, Schmitz PI, Hoogsteden H, van Klaveren RJ.
    Lung Cancer; 2009 Dec 15; 66(3):333-7. PubMed ID: 19327865
    [Abstract] [Full Text] [Related]

  • 16. A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.
    Chen JS, Rau KM, Chen YY, Huang JS, Yang TS, Lin YC, Liau CT, Lee KD, Su YC, Kao RH.
    Cancer Chemother Pharmacol; 2009 Apr 15; 63(5):819-25. PubMed ID: 18663448
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K, Hoff PM, Ohtsu A, Loehrer PJ, Hyodo I, Wadler S, Wadleigh RG, O'Dwyer PJ, Muro K, Yamada Y, Boku N, Nagashima F, Abbruzzese JL.
    J Clin Oncol; 2004 Sep 01; 22(17):3466-74. PubMed ID: 15277535
    [Abstract] [Full Text] [Related]

  • 18. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ, Meyers FJ, Houston J, Lauder I.
    Semin Oncol; 1997 Oct 01; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [Abstract] [Full Text] [Related]

  • 19. 5-FU or UFT combined with leucovorin for previously untreated metastatic colorectal Ca.
    Skillings JR.
    Oncology (Williston Park); 1997 Sep 01; 11(9 Suppl 10):48-9. PubMed ID: 9348568
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
    Bhandari MS, Pienta KJ, Fardig J, Olson K, Smith DC.
    Cancer; 2006 Apr 15; 106(8):1715-21. PubMed ID: 16534795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.